YU95186A - Process for obtaining substituted 1,2,3,5-tetrahydroimidazo(2,1-b)hynazolin-2-(1h)-ones - Google Patents
Process for obtaining substituted 1,2,3,5-tetrahydroimidazo(2,1-b)hynazolin-2-(1h)-onesInfo
- Publication number
- YU95186A YU95186A YU00951/86A YU95186A YU95186A YU 95186 A YU95186 A YU 95186A YU 00951/86 A YU00951/86 A YU 00951/86A YU 95186 A YU95186 A YU 95186A YU 95186 A YU95186 A YU 95186A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- hynazolin
- tetrahydroimidazo
- ones
- obtaining substituted
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858514207A GB8514207D0 (en) | 1985-06-05 | 1985-06-05 | Cardiac stimulants |
| GB858527208A GB8527208D0 (en) | 1985-11-05 | 1985-11-05 | Cardiac stimulants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU95186A true YU95186A (en) | 1988-04-30 |
Family
ID=26289332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU00951/86A YU95186A (en) | 1985-06-05 | 1986-06-03 | Process for obtaining substituted 1,2,3,5-tetrahydroimidazo(2,1-b)hynazolin-2-(1h)-ones |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4783467A (da) |
| EP (1) | EP0205280A3 (da) |
| KR (1) | KR870001362B1 (da) |
| CN (1) | CN86103833A (da) |
| AU (1) | AU562773B2 (da) |
| CA (1) | CA1270486A (da) |
| DK (1) | DK262486A (da) |
| ES (2) | ES8708139A1 (da) |
| FI (1) | FI862375A (da) |
| GR (1) | GR861425B (da) |
| HU (1) | HU196408B (da) |
| IL (1) | IL79003A0 (da) |
| NO (1) | NO862233L (da) |
| NZ (1) | NZ216386A (da) |
| PT (1) | PT82702B (da) |
| YU (1) | YU95186A (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783467A (en) * | 1985-06-05 | 1988-11-08 | Pfizer Inc. | Tetrahydroimidazoquinazolinone inotropic agents |
| CA2113115A1 (en) * | 1991-07-29 | 1993-02-18 | Vlad E. Gregor | Quinazoline derivatives as acetylcholinesterase inhibitors |
| US7700608B2 (en) | 2004-08-04 | 2010-04-20 | Shire Holdings Ag | Quinazoline derivatives and their use in the treatment of thrombocythemia |
| US8426429B2 (en) * | 2004-08-06 | 2013-04-23 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| US8383637B2 (en) * | 2004-08-06 | 2013-02-26 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| US8436006B2 (en) * | 2004-08-06 | 2013-05-07 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| US7910597B2 (en) | 2006-11-28 | 2011-03-22 | Shire Llc | Substituted quinazolines |
| US8304420B2 (en) | 2006-11-28 | 2012-11-06 | Shire Llc | Substituted quinazolines for reducing platelet count |
| WO2022199627A1 (en) * | 2021-03-23 | 2022-09-29 | National Institute Of Biological Sciences, Beijing | Polycyclic compounds and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3932407A (en) * | 1973-11-19 | 1976-01-13 | Bristol-Myers Company | Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones |
| US3983120A (en) * | 1974-11-06 | 1976-09-28 | Bristol-Myers Company | Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones |
| US3983119A (en) * | 1974-11-06 | 1976-09-28 | Bristol-Myers Company | Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones |
| NL7807507A (nl) * | 1977-07-25 | 1979-01-29 | Hoffmann La Roche | Tricyclische verbindingen. |
| US4208521A (en) * | 1978-07-31 | 1980-06-17 | Bristol-Myers Company | Process for the preparation of imidazo[2,1-b]quinazolinones |
| CA1131631A (en) * | 1979-06-20 | 1982-09-14 | Madhukar S. Chodnekar | Quinazoline derivatives and pharmaceutical preparations |
| EP0054180A3 (de) * | 1980-12-16 | 1982-12-01 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Verfahren zur Herstellung eines Imidazochinazolinonderivates |
| JPS604186A (ja) * | 1983-06-21 | 1985-01-10 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン化合物 |
| JPS6028979A (ja) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン類化合物 |
| US4593029A (en) * | 1984-02-15 | 1986-06-03 | Syntex (U.S.A.) Inc. | Novel ω-(N-imidazolyl)alkyl ethers of 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones |
| US4783467A (en) * | 1985-06-05 | 1988-11-08 | Pfizer Inc. | Tetrahydroimidazoquinazolinone inotropic agents |
-
1986
- 1986-05-22 US US06/865,693 patent/US4783467A/en not_active Expired - Lifetime
- 1986-05-28 EP EP86304040A patent/EP0205280A3/en not_active Withdrawn
- 1986-06-02 IL IL79003A patent/IL79003A0/xx unknown
- 1986-06-02 GR GR861425A patent/GR861425B/el unknown
- 1986-06-03 YU YU00951/86A patent/YU95186A/xx unknown
- 1986-06-03 NZ NZ216386A patent/NZ216386A/xx unknown
- 1986-06-03 CA CA000510658A patent/CA1270486A/en not_active Expired - Lifetime
- 1986-06-03 PT PT82702A patent/PT82702B/pt not_active IP Right Cessation
- 1986-06-04 KR KR1019860004434A patent/KR870001362B1/ko not_active IP Right Cessation
- 1986-06-04 NO NO862233A patent/NO862233L/no unknown
- 1986-06-04 HU HU862365A patent/HU196408B/hu unknown
- 1986-06-04 AU AU58427/86A patent/AU562773B2/en not_active Ceased
- 1986-06-04 DK DK262486A patent/DK262486A/da not_active Application Discontinuation
- 1986-06-04 FI FI862375A patent/FI862375A/fi not_active Application Discontinuation
- 1986-06-04 ES ES555723A patent/ES8708139A1/es not_active Expired
- 1986-06-05 CN CN198686103833A patent/CN86103833A/zh active Pending
-
1987
- 1987-02-26 ES ES557427A patent/ES8800224A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NZ216386A (en) | 1988-08-30 |
| PT82702A (en) | 1986-07-01 |
| ES557427A0 (es) | 1987-10-16 |
| ES8708139A1 (es) | 1987-09-16 |
| FI862375A (fi) | 1986-12-06 |
| EP0205280A2 (en) | 1986-12-17 |
| AU562773B2 (en) | 1987-06-18 |
| CA1270486A (en) | 1990-06-19 |
| FI862375A0 (fi) | 1986-06-04 |
| ES555723A0 (es) | 1987-09-16 |
| US4783467A (en) | 1988-11-08 |
| NO862233L (no) | 1986-12-08 |
| GR861425B (en) | 1986-10-02 |
| EP0205280A3 (en) | 1988-11-30 |
| DK262486D0 (da) | 1986-06-04 |
| DK262486A (da) | 1987-02-16 |
| ES8800224A1 (es) | 1987-10-16 |
| PT82702B (pt) | 1988-12-15 |
| HU196408B (en) | 1988-11-28 |
| KR870001362B1 (ko) | 1987-07-20 |
| CN86103833A (zh) | 1986-12-31 |
| AU5842786A (en) | 1986-12-11 |
| HUT41793A (en) | 1987-05-28 |
| NO862233D0 (no) | 1986-06-04 |
| IL79003A0 (en) | 1986-09-30 |
| KR870000338A (ko) | 1987-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU154986A (en) | Process for obtaining bis-phosphitic compounds | |
| YU45020B (en) | Process for obtaining substituted pyrimidines | |
| DE3662256D1 (en) | Process for the preparation of (2,2)-paracyclophane | |
| DE3665581D1 (en) | 9-halogenprostaglandines, process for their manufacture | |
| YU121187A (en) | Process for obtaining 4-methyl-6-methyl-sulphinylthieno (3,2-6)pyrid-7(4h)-ones | |
| PT80178A (en) | Process for the preparation of substituted alpha-amino-acids | |
| DE3569375D1 (en) | Process for the preparation of 1,2-benzisothiazolones | |
| PH22107A (en) | 3-pyrazolo(1,5-a)pyrdinium cephem compounds | |
| YU95186A (en) | Process for obtaining substituted 1,2,3,5-tetrahydroimidazo(2,1-b)hynazolin-2-(1h)-ones | |
| DE3566403D1 (en) | Process for the preparation of pyrrolidone derivatives | |
| DE3563351D1 (en) | Process for the preparation of tetrachloro-benzo-1,4-dioxenes | |
| DE3568327D1 (en) | Process for the preparation of 2,3,5-trimethylbenzoquinone | |
| DE3476069D1 (en) | Improved process for the preparation of polyhydroxybutadienes | |
| YU5886A (en) | Process for obtaining 4,4-dialkyl-2-azetodinone | |
| ZA85591B (en) | Process and intermediates for the preparation of aryl substituted pyrido(1,4)benzodiazepines | |
| PT83799A (en) | Process for the preparation of novel 2,2:-bi-1h-imidazoles | |
| GR861895B (en) | Process for the preparation of 3,7-disubstituted-3-cephem compounds | |
| EP0198795A3 (en) | Process for the preparation of 1,4-diaminoanthraquinones | |
| IL76367A0 (en) | Improved process for cephalsporin intermediates | |
| IL76243A0 (en) | Process and intermediates for the preparation of aromatic-1,4-oxazepinones and-thiones | |
| DE3660597D1 (en) | Process for the preparation of 5-fluorotoluene-2,4-disulfochloride | |
| GB2165242B (en) | Process for the preparation of 1, 2-benzoxathiine derivatives | |
| EP0195738A3 (en) | Process for the preparation of n,n -diisopropyl-2-benzothiazyl-sulfenamide | |
| YU102587A (en) | Process for obtaining substituted ethandiimidamides | |
| EP0206293A3 (en) | Process for the preparation of 3,5-dichloro-2-pyridone |